We are pleased to inform you that we have received our new trading symbol. We are now trading on the OTCQB market under the symbol – EQUR. Please look us up. We continue to be a fully-reporting company with the United States Securities and Exchange Commission using our new name, E-QURE Corp., a company incorporated in the State of Delaware, USA.
We have established a wholly-owned subsidiary, domiciled in Israel, ESQURE Ltd, to manage all production activity, and manage, in a later stage of development, the second generation of our DST device.
We have completed the acquisition of the all the sample prototype devices and all proprietary intellectual property including the product manufacturing documents from third parties through ESQURE.
We have also several of our devices to be used in our FDA clinical trial. These were converted to 110V, tested, re-packaged and are ready to ship to the USA where our FDA trials will take place.
The Company has established a Scientific Advisory Board and proudly announced the nomination of two prominent members, Prof. Avi Ohri and Dr. Benzi Wiener. We are in the process of adding one or two additional members from the US wound care medical community.
As we have previously reported, the company filed an S1 (Registration Statement) with the SEC to allow share trading to our investors. We will publicly announce when we anticipate that our registration will be effective so investors can deposit their shares certificate in their accounts and be ready to trade their E-QURE shares on the OTCQB market.
The company is pleased to announce that has also added a new Board Member, Dr. Michael Sessler, a prominent businessman with medical education. We intend to add additional members, including highly qualified persons from the US business community, to our Board of Directors.
The company is participating in the upcoming Medica Convention in mid-Nov., to be held in Dusseldorf, Germany, at which we will present our E-QURE BST Device to the medical device community, and re-establish business connections for Europe